Predicting the survival probability of functional neuroendocrine tumors treated with peptide receptor radionuclide therapy: Serbian experience

Peptide receptor radionuclide therapy (PRRT) is a treatment option for well-differentiated, somatostatin receptor positive, unresectable or/and metastatic neuroendocrine tumors (NETs). Although high disease control rates seen with PRRT a significant number NET patients have a short progression-free...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Frontiers in endocrinology (Lausanne) Jg. 14; S. 1270421
Hauptverfasser:	Vukomanovic, Vladimir, Nedic, Katarina Vuleta, Radojevic, Marija Zivkovic, Dagovic, Aleksandar, Milosavljevic, Neda, Markovic, Marina, Ignjatovic, Vladimir, Simic Vukomanovic, Ivana, Djukic, Svetlana, Sreckovic, Marijana, Backovic, Milena, Vuleta, Marko, Djukic, Aleksandar, Vukicevic, Verica, Ignjatovic, Vesna
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Switzerland Frontiers Media S.A 04.01.2024
Schlagworte:	Adult Aged Biomarkers Disease Progression Endocrinology functional tumors Humans Middle Aged NET Neuroendocrine Tumors - drug therapy Octreotide - therapeutic use overall survival progression free survival PRRT Radioisotopes - therapeutic use Receptors, Peptide - therapeutic use Retrospective Studies Serbia - epidemiology Serbia overall survival PRRT functional tumors NET progression free survival
ISSN:	1664-2392, 1664-2392
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!